 |
|
Gd2(SO4)3 |
| Product |
Product Code |
Order or Specifications |
99%
Gadolinium Sulfate Solution
|
|
 |
99.9%
Gadolinium Sulfate Solution |
GD-S-03-SOL |
 |
99.99% Gadolinium Sulfate Solution |
GD-S-04-SOL |
 |
99.999% Gadolinium Sulfate Solution |
|
 |
|
Gadolinium Sulfate Solutions are moderate to highly concentrated liquid solutions of Gadolinium Sulfate. They are an excellent source of Gadolinium Sulfate for applications requiring solubabilzed materials. American Elements can prepare dissolved homogenous solutions at customer specified concentrations or to the maximum stoichiometric concentration. Packaging is available in 55 gallon drums, smaller units and larger liquid totes. American Elements maintains solution production facilities in the United States, Northern Europe (Liverpool, UK), Southern Europe (Milan, Italy), Australia and China to allow for lower freight costs and quicker delivery to our customers. .American Elements metal and rare earth compound solutions have numerous applications, but are commonly used in petrochemical cracking and automotive catalysts, water treatment, plating, textiles, research and in optic, laser, crystal and glass applications. Ultra high purity and high purity compositions improve both optical quality and usefulness as scientific standards. Nanoscale (See also Nanotechnology Information and Quantum Dots) elemental powders and suspensions, as alternative high surface area forms, may be considered. We also produce Gadolinium Sulfate Powder. Most metal sulfate compounds are readily soluble in water for uses such as water treatment, unlike fluorides and oxides which tend to be insoluble. Organometallic forms are soluble in organic solutions and sometimes in both aqueous and organic solutions. Metallic ions can also be dispersed utilizing suspended or coated nanoparticles (See also application discussion at Nanotechnology Information and at Quantum Dots) and deposited utilizing sputtering targets and evaporation materials for uses such as solar energy materials and fuel cells. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.
Gadolinium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f75d16s2. In its elemental form gadolinium's CAS number is 7440-54-2. The gadolinium atom has a radius of 178.7.pm and it's Van der Waals radius is unknown. Gadolinium is utilized for both its high magnetic moment (7.94µB) and in phosphors and scintillator material. When complexed with EDTA ligands, it is used as an injectable contrast agent for patients undergoing magnetic resonance imaging. Gadolinium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder.
|
| Formula |
CAS No. |
Appearance |
Molecular Weight |
| Gd2(SO4)3 |
13450-87-8 |
White to Clear Liquid |
602.68 |
|
|
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
|
Recent Research & Development for Gadolinium
-
Gadolinium chloride suppresses styrene-induced cytochrome P450s expression in rat liver.
Biomed Res. 2008 Dec;28(6):323-30.
-
Gadolinium and nephrogenic systemic fibrosis: association or causation.
Nephrology (Carlton). 2008 Jun;13(3):235-41. Epub 2008 Jan 23.
-
Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
Int J Cancer. 2008 May 1;122(9):1981-6.
-
Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.
Skeletal Radiol. 2008 May;37(5):457-64. Epub 2008 Mar 7.
-
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
AJR Am J Roentgenol. 2008 Apr;190(4):1060-8.
-
MRI of mandibular osteonecrosis secondary to bisphosphonates.
AJR Am J Roentgenol. 2008 Apr;190(4):949-55.
-
Rapid and quantitative DNA analysis of genetic mutations for polycystic kidney disease (PKD) using magnetic/luminescent nanoparticles.
Anal Bioanal Chem. 2008 Apr;390(7):1829-35. Epub 2008 Feb 7.
-
Differential regulation of neutrophil CD18 integrin function by di- and tri-valent cations: manganese vs. gadolinium.
Ann Biomed Eng. 2008 Apr;36(4):647-60. Epub 2008 Mar 4.
-
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
Ann Rheum Dis. 2008 Apr;67(4):511-7. Epub 2007 Jul 20.
-
Molecular imaging of {alpha}v{beta}3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
Cardiovasc Res. 2008 Apr 1;78(1):148-57. Epub 2008 Jan 3.
-
Preconditioning with death ligands FasL and TNF-alpha protects the cirrhotic mouse liver against ischaemic injury.
Gut. 2008 Apr;57(4):492-9. Epub 2007 Dec 13.
-
Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging: Comparison with a Standard T2-Weighted Sequence for Detection of Focal Liver Lesions.
Invest Radiol. 2008 Apr;43(4):261-266.
-
Left Ventricular Postmyocardial Infarction Remodeling Studied by Combining MR-Tagging With Delayed MR Contrast Enhancement.
Invest Radiol. 2008 Apr;43(4):219-228.
-
Synthesis of a new gadolinium complex with a high affinity for human serum albumin and its manifold physicochemical characterization by proton relaxation rate analysis, NMR diffusometry and electrospray mass spectrometry.
J Inorg Biochem. 2008 Apr;102(4):721-30. Epub 2007 Nov 17.
-
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
J Pathol. 2008 Apr;214(5):584-93.
-
Optimized 3D bright blood MRI of aortic plaque at 3 T.
Magn Reson Imaging. 2008 Apr;26(3):330-6. Epub 2008 Feb 20.
-
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Nephrol Dial Transplant. 2008 Apr;23(4):1467. No abstract available.
-
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Nephrol Dial Transplant. 2008 Apr;23(4):1233-40. Epub 2008 Feb 5.
-
Regulation of stretch-activated ANP secretion by chloride channels.
Peptides. 2008 Apr;29(4):613-21. Epub 2007 Dec 8.
-
Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
Radiology. 2008 Apr;247(1):88-97. Epub 2008 Feb 21.
|
|